INS and metabolic dysfunction-associated steatotic liver disease: Data reported showed a decrease in body weight, an increase in insulin sensitivity, and an improvement within NAFLD parameters such as liver echogenicity and texture, decreased ALT, alkaline phosphatases, γ-glutamyltransferase, and coagulation factors II, VII, and X [21].